Initial Statement of Beneficial Ownership (3)

Date : 05/13/2019 @ 9:05PM
Source : Edgar (US Regulatory)
Stock : Diplomat Pharmacy Inc (DPLO)
Quote : 4.0  0.0 (0.00%) @ 12:00AM
Diplomat Pharmacy share price Chart

Initial Statement of Beneficial Ownership (3)

FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Loschinskey Dave

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/2/2019 

3. Issuer Name and Ticker or Trading Symbol

Diplomat Pharmacy, Inc. [DPLO]

(Last)        (First)        (Middle)

C/O DIPLOMAT PHARMACY, INC., 4100 SOUTH SAGINAW ST.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Operating Officer /

(Street)

FLINT, MI 48507       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   100822   (1) D    
Common Stock   994   I   By Spouse   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option to Acquire Common Stock     (3) 11/6/2027   Common Stock   100000   $20.87   D    
Employee Stock Option to Acquire Common Stock     (4) 3/27/2028   Common Stock   9508   $20.52   D    

Explanation of Responses:
(1)  Includes 1,778 restricted stock units granted in connection with the Issuer's equity incentive plan, one half of which will vest on March 27, 2020 and one half of which will vest on March 27, 2021.
(2)  Shares held directly by the Reporting Person's spouse.
(3)  The options were granted on November 6, 2017, in connection with the Reporting Person joining the Issuer, under the Issuer's equity incentive plan. One-fourth of the options vested on November 6, 2018 and the remaining three-fourths will vest on each of the second, third and fourth anniversary of the grant date.
(4)  The options were granted on March 27, 2018 in connection with the Issuer's equity incentive plan. One-third of the options vested on March 27, 2019 and the remaining two-thirds will vest on each of the second and third anniversary of the grant date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Loschinskey Dave
C/O DIPLOMAT PHARMACY, INC.
4100 SOUTH SAGINAW ST.
FLINT, MI 48507


Chief Operating Officer

Signatures
/s/ Christina Flint, by Power of Attorney 5/13/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Diplomat Pharmacy (NYSE:DPLO)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more Diplomat Pharmacy Charts.

Diplomat Pharmacy (NYSE:DPLO)
Intraday Stock Chart

Today : Sunday 23 February 2020

Click Here for more Diplomat Pharmacy Charts.

Latest DPLO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200223 22:39:55